FOSTAIR NEXTHALER is a prescription medication designed for the management and treatment of asthma and chronic obstructive pulmonary disease (COPD). It is an inhalation powder that combines two active ingredients: beclometasone dipropionate, a corticosteroid that reduces inflammation in the lungs, and formoterol fumarate dihydrate, a long-acting beta2-adrenergic agonist that helps to relax and widen the airways. This combination makes FOSTAIR NEXTHALER effective in preventing the symptoms of breathlessness and wheezing, offering improved breathing for individuals with asthma or COPD. It is typically used as a maintenance therapy, requiring regular use as directed by a healthcare professional. The Nexthaler device is designed for ease of use, providing a measured dose of the medication directly to the lungs.